NIDA is offering the Translational Avant-Garde Award to support researchers in developing medications for treating Substance Use Disorders. The grant aims to advance molecules with the potential to treat SUDs such as tobacco, cannabis, cocaine, and heroin, moving them closer to FDA approval. Researchers with expertise in drug development are encouraged to apply before the closing date on Jul 28, 2016.
Opportunity ID: 282052
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-17-015 |
| Funding Opportunity Title: | NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 09, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 28, 2016 |
| Current Closing Date for Applications: | Jul 28, 2016 |
| Archive Date: | Aug 28, 2016 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments County governments City or township governments Small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-015.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00221623 | Jun 28, 2016 | Jul 28, 2016 | View |
Package 1
Mandatory forms
282052 RR_SF424_2_0-2.0.pdf
282052 PHS398_CoverPageSupplement_3_0-3.0.pdf
282052 RR_OtherProjectInfo_1_3-1.3.pdf
282052 PerformanceSite_2_0-2.0.pdf
282052 RR_KeyPersonExpanded_2_0-2.0.pdf
282052 RR_Budget_1_3-1.3.pdf
282052 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
282052 RR_SubawardBudget30_1_3-1.3.pdf
282052 PHS_Inclusion_Enrollment_Report-1.0.pdf
282052 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
